GUIDED THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
GUIDED THERAPEUTICS, INC. (GTHP) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 5.18 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-05-15
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-03-31 was 5.18M shares, a 101.38% increase year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 4.74M shares, a 0.93% decline year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 596.55K shares, a 86.34% decline year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-06-30 was 85.00K shares, a 15.00% decline year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 7.99M shares, a 21.28% decline from fiscal 2024.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 10.15M shares, a 15.58% increase from fiscal 2023.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 8.78M shares, a 63.74% decline from fiscal 2022.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 24.22M shares, a 203.46% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2026-03-31 | 5.18M shares 10-Q · filed 2026-05-15 | 9.92M shares derived: sum of 2 quarters · filed 2026-05-15 | 10.51M shares derived: sum of 3 quarters · filed 2026-05-15 | 10.60M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 4.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 5.34M shares derived: sum of 2 quarters · filed 2026-03-31 | 5.42M shares derived: sum of 3 quarters · filed 2026-03-31 | 7.99M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 596.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 681.55K shares derived: sum of 2 quarters · filed 2025-11-13 | 3.25M shares 10-Q · filed 2025-11-13 | 8.04M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | 85.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 2.66M shares 10-Q · filed 2025-08-14 | 7.44M shares derived: sum of 3 quarters · filed 2026-05-15 | 11.81M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | 2.57M shares 10-Q · filed 2026-05-15 | 7.35M shares derived: sum of 2 quarters · filed 2026-05-15 | 11.72M shares derived: sum of 3 quarters · filed 2026-05-15 | 11.82M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 4.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 9.15M shares derived: sum of 2 quarters · filed 2026-03-31 | 9.25M shares derived: sum of 3 quarters · filed 2026-03-31 | 10.15M shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 4.37M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 4.47M shares derived: sum of 2 quarters · filed 2025-11-13 | 5.37M shares 10-Q · filed 2025-11-13 | 7.38M shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 100.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 1.00M shares 10-Q · filed 2025-08-14 | 3.01M shares derived: sum of 3 quarters · filed 2025-08-14 | 3.91M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 900.00K shares 10-Q · filed 2025-05-15 | 2.91M shares derived: sum of 2 quarters · filed 2025-05-15 | 3.81M shares derived: sum of 3 quarters · filed 2025-05-15 | 7.81M shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | 2.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.91M shares derived: sum of 2 quarters · filed 2025-03-31 | 6.91M shares derived: sum of 3 quarters · filed 2025-03-31 | 8.78M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 900.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 4.90M shares derived: sum of 2 quarters · filed 2024-11-14 | 6.77M shares 10-Q · filed 2024-11-14 | |
| 2023-06-30 | 4.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 5.87M shares 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | 1.87M shares 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | 24.22M shares 10-K · filed 2024-03-28 | |||
| 2021-12-31 | 7.98M shares 10-K · filed 2023-03-30 | |||
| 2021-06-30 | 1.99M shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-18 | 3.44M shares 10-Q · filed 2021-08-18 | 3.44M shares derived: sum of 3 quarters · filed 2022-03-30 | 3.44M shares derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-03-31 | 1.45M shares 10-Q/A · filed 2021-08-18 | 1.45M shares derived: sum of 2 quarters · filed 2022-03-30 | 1.45M shares derived: sum of 3 quarters · filed 2022-03-30 | 2.56M shares derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-30 | 1.00K shares derived: sum of 2 quarters · filed 2022-03-30 | 1.11M shares derived: sum of 3 quarters · filed 2022-03-30 | 11.27M shares 10-K · filed 2022-03-30 |
| 2020-09-30 | 1.00K shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-05 | 1.11M shares derived: sum of 2 quarters · filed 2020-11-05 | 11.27M shares 10-Q/A · filed 2020-11-05 | |
| 2020-06-30 | 1.11M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-20 | 11.27M shares 10-Q · filed 2020-08-20 | ||
| 2020-03-31 | 10.16M shares 10-Q · filed 2020-07-07 |